GlassScriptPhysician profile
Edith Torres
NPI 1295474377
$5,210.17
in general payments reported to CMS, 2019-2025
19 companies · $2,937 in 2025
The $2,937 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $171 · 2023: $429 · 2024: $1,673 · 2025: $2,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,657 · Education: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,656.53 |
| Education | $382.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $916.13 | 2022-2025 | Sotyktu |
| Ucb, INC. | $851.24 | 2023-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $463.81 | 2024-2025 | |
| Genzyme Corporation | $417.99 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $410.89 | 2024-2025 | Dupixent |
| Janssen Biotech, INC. | $405.26 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $246.67 | 2022-2025 | Ebglyss, Taltz, Olumiant |
| Pfizer INC. | $238.92 | 2024-2025 | |
| Organon LLC | $227.30 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $204.88 | 2024-2025 | Zoryve |
| Incyte Corporation | $183.18 | 2022-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $163.94 | 2024-2025 | |
| Galderma Laboratories, L.P. | $115.37 | 2022-2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Amgen INC. | $82.53 | 2024-2025 | Otezla, Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medimetriks Pharmaceuticals, INC. | $76.42 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $64.57 | 2025 | |
| Leo Pharma INC. | $22.01 | 2024 | Adbry |
| Convatec INC. | $20.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.